Association of polymorphism of TLR4 and CD14 genes with gastroduodenal diseases in Japan

Tomomitsu Tahara, T. Arisawa, T. Shibata, I. Hirata, H. Nakano

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Host genetic factors may play a key role in determining the long-term outcome of the Helicobacter pylori infection. Toll like receptor 4(TLR4) and CD14-mediated recognition of lipo-polysaccharide (LPS) is required for efficient recognition of Gram-negative bacterial infections. Aims: We investigated the effects of common polymorphisms of TLR4 Asp299Gly, Thr399Ile and CD14 promoter -C159T on the risk of gastric cancer including its subtypes and clinicopathologic features. We also investigated the effects of these polymorphisms on histologic degree of H. pylori induced gastritis. Subjects: The study was performed in 149 gastric cancer(GC) cases [mean age 64.0 ±12.4, M:F = 109:40] and 94 patients without evidence of GC (mean age 64.1 ±12.3, M:F = 65:25, Peptic ulcer diseases = 43.6%, gastritis = 56.4%) as the control group. Methods: TLR4 Asp299Gly, Thr399Ile and CD14 promoter - C159T were determined by PCR-RFLP in all the patients. Gastritis scores of non-cancerous gastric mucosa were assessed according to the updated Sydney system in H. pylori-positive subjects(n = 174). Results: The frequencies of CD14-260 TT and T carrier were significantly lower in patents with intestinal type gastric cancer than in controls (OR = 0.31;95% CI = 0.12-0.78, OR = 0.38; 95% CI = 0.18-0.81, respectively) Compared with patients older than 61 years, the atrophy score in antrum was significantly lower in TT and CT patients.TLR4 Asp299Gly, Thr399Ile were not detected in all the patients. Conclusion: Our data suggest that CD14 promoter-159TT and T carrier were associated with lower risk of developing gastric mucosal atrophy in H. pylori infected patients more than 61 years of age, and these genotypes may reduce the risk of intestinal type gastric cancer and TLR4 Asp299Gly, Thr399Ile are very rare in the Japanese population.

Original languageEnglish
Pages (from-to)124-128
Number of pages5
JournalInflammopharmacology
Volume15
Issue number3
DOIs
Publication statusPublished - 01-06-2007

Fingerprint

Toll-Like Receptor 4
Japan
Stomach Neoplasms
Helicobacter pylori
Gastritis
Genes
Intestinal Neoplasms
Atrophy
Gram-Negative Bacterial Infections
Patents
Helicobacter Infections
Gastric Mucosa
Peptic Ulcer
Restriction Fragment Length Polymorphisms
Polysaccharides
Stomach
Genotype
Polymerase Chain Reaction
Control Groups
Population

All Science Journal Classification (ASJC) codes

  • Immunology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Tahara, Tomomitsu ; Arisawa, T. ; Shibata, T. ; Hirata, I. ; Nakano, H. / Association of polymorphism of TLR4 and CD14 genes with gastroduodenal diseases in Japan. In: Inflammopharmacology. 2007 ; Vol. 15, No. 3. pp. 124-128.
@article{706b4843b85647fe8376ca0bcb5b2974,
title = "Association of polymorphism of TLR4 and CD14 genes with gastroduodenal diseases in Japan",
abstract = "Background: Host genetic factors may play a key role in determining the long-term outcome of the Helicobacter pylori infection. Toll like receptor 4(TLR4) and CD14-mediated recognition of lipo-polysaccharide (LPS) is required for efficient recognition of Gram-negative bacterial infections. Aims: We investigated the effects of common polymorphisms of TLR4 Asp299Gly, Thr399Ile and CD14 promoter -C159T on the risk of gastric cancer including its subtypes and clinicopathologic features. We also investigated the effects of these polymorphisms on histologic degree of H. pylori induced gastritis. Subjects: The study was performed in 149 gastric cancer(GC) cases [mean age 64.0 ±12.4, M:F = 109:40] and 94 patients without evidence of GC (mean age 64.1 ±12.3, M:F = 65:25, Peptic ulcer diseases = 43.6{\%}, gastritis = 56.4{\%}) as the control group. Methods: TLR4 Asp299Gly, Thr399Ile and CD14 promoter - C159T were determined by PCR-RFLP in all the patients. Gastritis scores of non-cancerous gastric mucosa were assessed according to the updated Sydney system in H. pylori-positive subjects(n = 174). Results: The frequencies of CD14-260 TT and T carrier were significantly lower in patents with intestinal type gastric cancer than in controls (OR = 0.31;95{\%} CI = 0.12-0.78, OR = 0.38; 95{\%} CI = 0.18-0.81, respectively) Compared with patients older than 61 years, the atrophy score in antrum was significantly lower in TT and CT patients.TLR4 Asp299Gly, Thr399Ile were not detected in all the patients. Conclusion: Our data suggest that CD14 promoter-159TT and T carrier were associated with lower risk of developing gastric mucosal atrophy in H. pylori infected patients more than 61 years of age, and these genotypes may reduce the risk of intestinal type gastric cancer and TLR4 Asp299Gly, Thr399Ile are very rare in the Japanese population.",
author = "Tomomitsu Tahara and T. Arisawa and T. Shibata and I. Hirata and H. Nakano",
year = "2007",
month = "6",
day = "1",
doi = "10.1007/s10787-006-1567-8",
language = "English",
volume = "15",
pages = "124--128",
journal = "Inflammopharmacology",
issn = "0925-4692",
publisher = "Birkhauser Verlag Basel",
number = "3",

}

Association of polymorphism of TLR4 and CD14 genes with gastroduodenal diseases in Japan. / Tahara, Tomomitsu; Arisawa, T.; Shibata, T.; Hirata, I.; Nakano, H.

In: Inflammopharmacology, Vol. 15, No. 3, 01.06.2007, p. 124-128.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Association of polymorphism of TLR4 and CD14 genes with gastroduodenal diseases in Japan

AU - Tahara, Tomomitsu

AU - Arisawa, T.

AU - Shibata, T.

AU - Hirata, I.

AU - Nakano, H.

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Background: Host genetic factors may play a key role in determining the long-term outcome of the Helicobacter pylori infection. Toll like receptor 4(TLR4) and CD14-mediated recognition of lipo-polysaccharide (LPS) is required for efficient recognition of Gram-negative bacterial infections. Aims: We investigated the effects of common polymorphisms of TLR4 Asp299Gly, Thr399Ile and CD14 promoter -C159T on the risk of gastric cancer including its subtypes and clinicopathologic features. We also investigated the effects of these polymorphisms on histologic degree of H. pylori induced gastritis. Subjects: The study was performed in 149 gastric cancer(GC) cases [mean age 64.0 ±12.4, M:F = 109:40] and 94 patients without evidence of GC (mean age 64.1 ±12.3, M:F = 65:25, Peptic ulcer diseases = 43.6%, gastritis = 56.4%) as the control group. Methods: TLR4 Asp299Gly, Thr399Ile and CD14 promoter - C159T were determined by PCR-RFLP in all the patients. Gastritis scores of non-cancerous gastric mucosa were assessed according to the updated Sydney system in H. pylori-positive subjects(n = 174). Results: The frequencies of CD14-260 TT and T carrier were significantly lower in patents with intestinal type gastric cancer than in controls (OR = 0.31;95% CI = 0.12-0.78, OR = 0.38; 95% CI = 0.18-0.81, respectively) Compared with patients older than 61 years, the atrophy score in antrum was significantly lower in TT and CT patients.TLR4 Asp299Gly, Thr399Ile were not detected in all the patients. Conclusion: Our data suggest that CD14 promoter-159TT and T carrier were associated with lower risk of developing gastric mucosal atrophy in H. pylori infected patients more than 61 years of age, and these genotypes may reduce the risk of intestinal type gastric cancer and TLR4 Asp299Gly, Thr399Ile are very rare in the Japanese population.

AB - Background: Host genetic factors may play a key role in determining the long-term outcome of the Helicobacter pylori infection. Toll like receptor 4(TLR4) and CD14-mediated recognition of lipo-polysaccharide (LPS) is required for efficient recognition of Gram-negative bacterial infections. Aims: We investigated the effects of common polymorphisms of TLR4 Asp299Gly, Thr399Ile and CD14 promoter -C159T on the risk of gastric cancer including its subtypes and clinicopathologic features. We also investigated the effects of these polymorphisms on histologic degree of H. pylori induced gastritis. Subjects: The study was performed in 149 gastric cancer(GC) cases [mean age 64.0 ±12.4, M:F = 109:40] and 94 patients without evidence of GC (mean age 64.1 ±12.3, M:F = 65:25, Peptic ulcer diseases = 43.6%, gastritis = 56.4%) as the control group. Methods: TLR4 Asp299Gly, Thr399Ile and CD14 promoter - C159T were determined by PCR-RFLP in all the patients. Gastritis scores of non-cancerous gastric mucosa were assessed according to the updated Sydney system in H. pylori-positive subjects(n = 174). Results: The frequencies of CD14-260 TT and T carrier were significantly lower in patents with intestinal type gastric cancer than in controls (OR = 0.31;95% CI = 0.12-0.78, OR = 0.38; 95% CI = 0.18-0.81, respectively) Compared with patients older than 61 years, the atrophy score in antrum was significantly lower in TT and CT patients.TLR4 Asp299Gly, Thr399Ile were not detected in all the patients. Conclusion: Our data suggest that CD14 promoter-159TT and T carrier were associated with lower risk of developing gastric mucosal atrophy in H. pylori infected patients more than 61 years of age, and these genotypes may reduce the risk of intestinal type gastric cancer and TLR4 Asp299Gly, Thr399Ile are very rare in the Japanese population.

UR - http://www.scopus.com/inward/record.url?scp=34347380128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347380128&partnerID=8YFLogxK

U2 - 10.1007/s10787-006-1567-8

DO - 10.1007/s10787-006-1567-8

M3 - Article

C2 - 19847953

AN - SCOPUS:34347380128

VL - 15

SP - 124

EP - 128

JO - Inflammopharmacology

JF - Inflammopharmacology

SN - 0925-4692

IS - 3

ER -